Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3341-3345

  Stephenson, Stacy M ^a   Yang, Weilian ^a   Stevens, Phillip J ^a   Tjarks, Werner ^a   Barth, Rolf F ^a   Lee, Robert J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b College of Pharmacy ^*  (United States)

Author keywords

Folate receptor; Liposome; Neutron capture therapy; Tumor targeting

Indexed keywords

BORON; FOLIC ACID; LIPOSOME;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; IMPLANT; MOUSE; MOUTH CARCINOMA; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; XENOGRAFT;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARRIER PROTEINS; DRUG CARRIERS; FEMALE; HUMANS; KB CELLS; LIPOSOMES; MICE; MICE, NUDE; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0042530136     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barth RF, Soloway AH, Goodman JH, Gahbauer RA, Gupta N, Blue TE, Yang W and Tjarks W: Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44 (3): 433-451, 1999.
2. Barth RF: A critical assessment of boron neutron capture therapy: An overview. J Neuro-Oncol, 2003 (in press).
3. Shelly K, Feakes DA, Hawthorne MF, Schmidt PG, Krisch TA and Bauer WF: Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes. Proc Natl Acad Sc USA 89: 9039-9043, 1992.
4. 3]: synthesis and liposomal delivery to murine tumors. Proc Natl Acad Sci USA 91: 3029-3033, 1994.
5. Hawthorne MF and Shelly K: Liposomes as drug delivery vehicles for boron agents. J Neuro-Oncol 33: 53-58, 1997.
6. Matsumura Y and Maeda H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387-6392, 1986.
7. Jain RK: Delivery of molecular and cellular medicine to solid tumors. J Control Release 53: 49-67, 1998.
8. Yanagie H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi K, Eriguchi M, Kobayashi T and Ono K: Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Brit J Cancer 75: 660-665, 1997.
9. Antony AC: Folate receptors. Annu Rev Nutr 15: 501-521, 1996.
10. Lee RJ and Low PS: Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233: 133-144, 1995.
11. Cho Bryan K, Roy EJ, Patrick TA and Kranz DM: Single-chain Fv/Folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconjugate Chem 8: 338-346, 1997.
12. Konda SD, Aref M, Wang S, Brechbiel M and Wiener EC: Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts: Mag Res Mat Phys Biol Med 12: 104-113, 2001.
13. Sudimack J, Adams D, Rotaru J, Shukla S, Yan J, Sekido M, Barth RF, Tjarks W and Lee RJ: Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharm Res 19: 1502-1508, 2002.
14. Guo W, Sudimack J and Lee RJ: Receptor-specific delivery of liposomes via folate PEG-chol: J Liposome Res 10: 179-195, 2000.
15. Barth RF, Adams DM, Soloway AH, Mechetner EB, Alam F and Anisuzzaman AK: Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal Chem 63: 890-893, 1991.
16. Pan XQ, Wang H and Lee RJ: Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes: Anticancer Res 22: 1629-1634, 2002.
17. Pan XQ, Wang H, Shukla S, Sekido M, Adams DM, Tjarks W, Barth RF and Lee RJ: Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjugate Chem 13(3): 435-442, 2002.
18. Garin-Chesa P, Campbell I, Saigo PE, Lewis Jr JL, Old JL and Rettig WJ: Trophoblast and Ovarian Cancer Antigen LK2. Am J Pathol 142(2): 557-567, 1993.
19. Yang W, Barth RF, Adams DM et at: Boron neutron capture therapy (BNCT) of brain tumors: Convection enhanced delivery of boronated epidermal growth factor to EGF receptor positive gliomas. J Neuro-Oncol 2: 304-2000.
20. Koukourakis MI, Koukouraki S, Fezoulidid I, Kelekis N, Kyrias G, Archimandritis S and Karkavitsas N.: High intratumoural accumulation of stealth® liposomal doxorubicin (Caelys®) in glioblastomas and in metastatic brain tumours. Brit J Cancer 83(10): 1281-1286, 2000.
21. Cho BK, Roy EJ, Patrick TA, Kranz DM: Single-chain Fv/Folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Bioconjugate Chem 8: 338-346, 1997.
22. Roy EJ, Cho BK, Rund LA, Patrick TA and Kranz DM: Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate. Int J Cancer 76: 761-766, 1998.
23. Israel VP, Garcia AA, Roman L, Muderspach L, Burnett A, Jeffers S and Muggia FM: Phase II study of liposomal doxorubicin in advanced gynecologic cancers. Gynecol Oncol 78: 143-147, 2000.
24. 2) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum. Gynecol Oncol 78: 369-372, 2000.
25. Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A and Seiden MV: The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol 81: 206-212, 2001.
26. Xing PQ, Zheng X, Shi G, Wang H, Ratnam M and Lee RJ: Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 100(2): 594-602, 2002.
27. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S and Gabizon A: Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug resistant efflux pump. Clin Cancer Res 6(5): 1949-57, 2000.